Categories

Most recent posts

  XML Feeds

Search

« Will Health Insurance Exchanges Get Rebranded?Strong Teeth Requires Healthy Habits »

FDA Panels Recommend HIV, Weight Loss Drugs; Agency Offers MS Treatment Warning

05/11/12

  10:58:12 am, by MedBen5   , 225 words,  
Categories: News, Prescription, Wellness

FDA Panels Recommend HIV, Weight Loss Drugs; Agency Offers MS Treatment Warning

The Food and Drug Administration is all over the news today:

  • An FDA advisory panel has recommended approval of the drug Truvada to prevent the spread of HIV infection in high-risk, healthy people, WebMD reports.

    The Antiviral Drugs Advisory Committee recommended the agency allow the drug’s use for men who have sex with men; uninfected partners of HIV-positive partners; and others at risk of infection through sexual activity. Truvada was approved in 2004 to treat people already infected with HIV, the virus that causes AIDS.

  • The New York Times reports that FDA advisors have recommended approval of the weight-loss drug lorcaserin, saying that its benefits outweighed potential risks. If the agency approves the drug by its scheduled deadline of June 27, lorcaserin would be the first new prescription diet pill to reach the market in 13 years.

    Earlier this year, an advisory committee recommended approval of the weight-loss drug Qnexa. The agency is expected to decide whether to approve it by July 17.

  • The FDA has warned against the use of an experimental treatment for multiple sclerosis, the Los Angeles Times reports. Known as liberation therapy, the treatment is meant to open narrowed veins in the head and neck via the insertion of balloons or stents.

    The agency claims that the therapy has caused death, strokes, nerve damage and abdominal bleeding and has no proven benefits for MS sufferers.

No feedback yet